Reference Article

from Wikipedia, the free encyclopedia

Anti-obesity drug

Anti-obesity drugs include all pharmacological treatments intended to reduce or control weight.

Because these drugs are intended to alter one of the fundamental processes of the human body, anti-obesity drugs are medically prescribed only in cases of morbid obesity, where weight loss is life-saving.

Anti-obesity drugs operate through one or more of the following mechanisms: Suppression of the appetite.

Epilepsy medications and catecholamines and their derivatives (such as amphetamine-based drugs) are the main tools used for this.

Drugs blocking the cannabinoid receptors may be a future strategy for appetite suppression.[citation needed] Increase of the body's metabolism.[citation needed] Interference with the body's ability to absorb specific nutrients in food.

For example, Orlistat (also known as Xenical and Allī) blocks fat breakdown and thereby prevents fat absorption.

The OTC fiber supplements glucomannan and guar gum have been used for the purpose of inhibiting digestion and lowering caloric absorption Anorectics (also known as anorexigenics) are primarily intended to suppress the appetite, but most of the drugs in this class also act as stimulants (dexedrine, e.g.), and patients have abused drugs "off label" to suppress appetite (e.g. digoxin).

Note: This article excerpts material from the Wikipedia article "Anti-obesity drug", which is released under the GNU Free Documentation License.

See the following related content on ScienceDaily:


Related Videos

last updated on 2014-10-24 at 3:18 pm EDT

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
US Obesity Rates Stable but Still High

US Obesity Rates Stable but Still High

Newsy (Aug. 17, 2013) A new report shows obesity rates remained steady in every state but Arkansas last year. However, obesity rates remain high nationwide.
Powered by NewsLook.com
Sex, Veggies Little to Do With Weight Loss

Sex, Veggies Little to Do With Weight Loss

AP (Jan. 30, 2013) Think having sex or going to gym class drives weight loss, or that breastfeeding protects a child from obesity? In fact, these are among seven popular obesity myths.
Powered by NewsLook.com
Federal Government Needs More Marijuana for Research Studies

Federal Government Needs More Marijuana for Research Studies

TheStreet (May 9, 2014) The National Institute for Drug Abuse, or NIDA, has asked the Drug Enforcement Agency for more marijuana. NIDA has requested an increase from 21,000 grams to 650,000 grams, or roughly 1,433 pounds of pot. As of January, NIDA has funded 28 active grants related to therapeutic uses of marijuana in six different disease categories covering AIDS, pain, schizophrenia, seizures and hard drug withdrawal. But NIDA frequently contradicts on the subject of marijuana: a NIDA-funded study at Yale looking at cannabis as a treatment for schizophrenia warned that marijuana could worsen the condition. NIDA gets its pot from The University of Mississippi, the only legal marijuana farm that grows pot for the government. The request is now open to the public for comment. Video provided by TheStreet
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins